Incannex Healthcare Inc - ADR

NAS:IXHL (Australia)   ADR
$ 1.66 0 (0%) 11:08 PM EST
At Loss
P/B:
4.52
Market Cap:
$ 29.29M
Enterprise V:
$ 25.54M
Volume:
4.66K
Avg Vol (2M):
35.82K
Trade In:
Volume:
4.66K
At Loss
Avg Vol (2M):
35.82K

Business Description

Incannex Healthcare Inc
NAICS : 325412 SIC : 2833
ISIN : US45333F1093

Share Class Description:

IXHL: ADR
Description
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
Name Current Vs Industry Vs History
Cash-To-Debt 8.83
Equity-to-Asset 0.41
Debt-to-Equity 0.06
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -12.54
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 26.82
9-Day RSI 30.16
14-Day RSI 35.52
6-1 Month Momentum % -17.56
12-1 Month Momentum % -49.91

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.65
Quick Ratio 1.65
Cash Ratio 0.39

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.2
Shareholder Yield % -0.26

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -27039.54
Net Margin % -26922.09
FCF Margin % -14354.65
ROE % -182.23
ROA % -127.38
ROIC % -458.35
ROC (Joel Greenblatt) % -2553.98
ROCE % -179.56

Financials (Next Earnings Date:2025-02-14 Est.)

IXHL's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IXHL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Incannex Healthcare Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.086
EPS (TTM) ($) -1.39
Beta 0
Volatility % 97.03
14-Day RSI 35.52
14-Day ATR ($) 0.143771
20-Day SMA ($) 1.97293
12-1 Month Momentum % -49.91
52-Week Range ($) 1.5 - 8.4697
Shares Outstanding (Mil) 17.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Incannex Healthcare Inc Filings

Filing Date Document Date Form
No Filing Data

Incannex Healthcare Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Incannex Healthcare Inc Frequently Asked Questions

What is Incannex Healthcare Inc(IXHL)'s stock price today?
The current price of IXHL is $1.66. The 52 week high of IXHL is $8.47 and 52 week low is $1.50.
When is next earnings date of Incannex Healthcare Inc(IXHL)?
The next earnings date of Incannex Healthcare Inc(IXHL) is 2025-02-14 Est..
Does Incannex Healthcare Inc(IXHL) pay dividends? If so, how much?
Incannex Healthcare Inc(IXHL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1